Back

News

Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.

  1. News

News


Supporting Patients for Accelerated Diagnosis and Treatment Development

Cambridge, MA USA & Rostock, Germany December...


Cambridge, MA USA & Rostock, Germany December 6, 2019 – CENTOGENE (Nasdaq: CNTG) today announced the expansion of its...


CAMBRIDGE, Mass. and ROSTOCK and BERLIN, Germany, November 21, 2019 (GLOBE NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a...


ROSTOCK/BERLIN, Deutschland und CAMBRIDGE, MA, USA 21. November 2019 (GLOBE NEWSWIRE) - CENTOGENE (Nasdaq: CNTG), ein...


Focus on Aromatic L-amino Acid Decarboxylase (AADC) Deficiency


Accelerating new rare disease therapies through collaboration agreement


Global award honors entrepreneurship, innovation, and personal commitment


Supporting rare disease diagnosis, education, and clinical research


Driving Accelerated Diagnosis and Treatment Development


Driving personalized, immune-based therapy to target patients’ own immune responses